Author

jens kjeldsen

THE DIAGNOSTIC PERFORMANCE OF PAN-ENTERIC CAPSULE ENDOSCOPY AND MAGNETIC RESONANCE ENTEROCOLONOGRAPHY IN PATIENTS WITH SUSPECTED CROHN’S DISEASE
THE DIAGNOSTIC PERFORMANCE OF PAN-ENTERIC CAPSULE ENDOSCOPY AND MAGNETIC RESONANCE ENTEROCOLONOGRAPHY IN PATIENTS WITH SUSPECTED CROHN’S DISEASE

jens kjeldsen  et al.

THE DIAGNOSTIC PERFORMANCE OF ARTIFICIAL INTELLIGENCE-ASSISTED ANALYSIS OF PAN-ENTERIC CAPSULE ENDOSCOPY IN PATIENTS WITH SUSPECTED CROHN’S DISEASE
THE DIAGNOSTIC PERFORMANCE OF ARTIFICIAL INTELLIGENCE-ASSISTED ANALYSIS OF PAN-ENTERIC CAPSULE ENDOSCOPY IN PATIENTS WITH SUSPECTED CROHN’S DISEASE

jens kjeldsen  et al.

LEARNING CURVES IN SMALL BOWEL CAPSULE ENDOSCOPY
LEARNING CURVES IN SMALL BOWEL CAPSULE ENDOSCOPY

jens kjeldsen  et al.

NON-INVASIVE BIOMARKERS OF TYPE III COLLAGEN CROSS-LINKING REFLECT FIBROLYSIS IN CROHN'S DISEASE PATIENTS WITH A NON-STRICTURING AND NON-PENETRATING DISEASE BEHAVIOUR
NON-INVASIVE BIOMARKERS OF TYPE III COLLAGEN CROSS-LINKING REFLECT FIBROLYSIS IN CROHN'S DISEASE PATIENTS WITH A NON-STRICTURING AND NON-PENETRATING DISEASE BEHAVIOUR

jens kjeldsen  et al.

A MARKER OF PROTEOLYTIC DEGRADATION OF CROSS-LINKED TYPE V COLLAGEN IS UPREGULATED IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
A MARKER OF PROTEOLYTIC DEGRADATION OF CROSS-LINKED TYPE V COLLAGEN IS UPREGULATED IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

jens kjeldsen  et al.

A BIOMARKER OF EARLY MUCOSAL DESTRUCTION: NEUTROPHIL-MEDIATED TYPE IV COLLAGEN DEGRADATION IS ELEVATED IN PATIENTS WITH CROHN’S DISEASE AND ULCERATIVE COLITIS
A BIOMARKER OF EARLY MUCOSAL DESTRUCTION: NEUTROPHIL-MEDIATED TYPE IV COLLAGEN DEGRADATION IS ELEVATED IN PATIENTS WITH CROHN’S DISEASE AND ULCERATIVE COLITIS

jens kjeldsen  et al.

VEDOLIZUMAB AS FIRST-LINE BIOLOGICAL THERAPY IN ELDERLY PATIENTS AND THOSE WITH CONTRAINDICATIONS FOR ANTI-TNF THERAPY: A REAL-WORLD, NATIONWIDE COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASES
VEDOLIZUMAB AS FIRST-LINE BIOLOGICAL THERAPY IN ELDERLY PATIENTS AND THOSE WITH CONTRAINDICATIONS FOR ANTI-TNF THERAPY: A REAL-WORLD, NATIONWIDE COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASES

jens kjeldsen  et al.

DISCONTINUATION OF INFLIXIMAB THERAPY IN PATIENTS WITH CROHN’S DISEASE IN SUSTAINED, COMBINED CLINICAL-BIOCHEMICAL-ENDOSCOPIC REMISSION: A DOUBLE-BLINDED, PLACEBO-CONTROLLED, RANDOMIZED CLINICAL TRIAL
DISCONTINUATION OF INFLIXIMAB THERAPY IN PATIENTS WITH CROHN’S DISEASE IN SUSTAINED, COMBINED CLINICAL-BIOCHEMICAL-ENDOSCOPIC REMISSION: A DOUBLE-BLINDED, PLACEBO-CONTROLLED, RANDOMIZED CLINICAL TRIAL

jens kjeldsen  et al.

Item 1 - 8 / 8
1